Two Sigma Investments, LP P Lx Pharma Inc. Transaction History

Two Sigma Investments, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.12 - $0.3 $0 - $2	-8 Reduced 0.06%	14,078 $1,000
Q4 2022 Feb 14, 2023	SELL	$0.15 - $0.63 $6,738 - $28,299	-44,920 Reduced 76.13%	14,086 $2,000
Q3 2022 Nov 14, 2022	SELL	$0.52 - $3.08 $60,377 - $357,618	-116,110 Reduced 66.3%	59,006 $38,000
Q2 2022 Aug 15, 2022	SELL	$1.9 - $4.18 $311,060 - $684,332	-163,716 Reduced 48.32%	175,116 $426,000
Q1 2022 May 16, 2022	SELL	$3.54 - $8.3 $305,533 - $716,364	-86,309 Reduced 20.3%	338,832 $1.37 Million

Q4 2021 Feb 14, 2022	BUY	$7.69 - $19.66 $765,654 - $1.96 Million	99,565 Added 30.58%	425,141 $3.41 Million
Q3 2021 Nov 15, 2021	BUY	$12.22 - $21.28 $2.06 Million - $3.58 Million	168,176 Added 106.85%	325,576 $6.28 Million
Q2 2021 Aug 16, 2021	BUY	$9.0 - $15.94 $483,849 - $856,950	53,761 Added 51.87%	157,400 $2.17 Million
Q1 2021 May 17, 2021	BUY	$5.24 - $10.14 $543,068 - $1.05 Million	103,639 New	103,639 $936,000

61.6K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.